Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance).

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance). Cancer. 2019 10 01; 125(19):3378-3389.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bendamustine Hydrochloride
Bortezomib
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Lymphoma, Follicular
Male
Middle Aged
Neoplasm Grading
Remission Induction

authors with profiles

Mei-Yin Polley